ContentsIssue 102 • January 2021In association withPharma in the age of BidenWith President-elect Joe Biden set to take office in January, how will his administration approach the pharma industry?IN DEPTHBrexit: preventing counterfeit drugsCommentIDMP: What lies ahead?BriefingIndustry newsPharma industry briefingCovid-19 briefingCommentPipeline agents in the RA marketThe rising role of the microbiome in R&DIMDP: the benefit of hindsightIn DepthSolving the puzzle of Hepatitis CIs self-medication the future of pharma?How do you fast-track a vaccine?Healthcare’s sustainability goalsNew Zealand: a promising trial destinationIn DataInside the dealDeals analysisMarket data02/23/2024 23:33:37
Comment
IDMP: What lies ahead?